Study title:
Uchida Y et al. Phase II study of NY-198 ophthalmic solution in multicenter double-blind design; Phase II study of NY-198 ophthalmic solution. No report date. Amendment to clinical trial report by Dr. A. Jauch, January 4, 1994, + Appendix 1 and 2.Uchida Y et al. Phase II study of NY-198 ophthalmic solution in multicenter double-blind design; Phase II study of NY-198 ophthalmic solution. No report date. Amendment to clinical trial report by Dr. A. Jauch, January 4, 1994, + Appendix 1 and 2.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Eye Diseases [C11]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: LOMEFLOXACIN |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|